Atea Pharmaceuticals (AVIR) Share-based Compensation (IS) (2024 - 2026)
Atea Pharmaceuticals' Share-based Compensation (IS) was $3.38 million in Q2 2026, down 27.6% from $4.67 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atea Pharmaceuticals' Share-based Compensation (IS) was $16.21 million through Jun 30, 2026, down 57.4% year-over-year; for FY2025, it came in at $20.72 million, down 60.0% from FY2024.
- In earlier years, Share-based Compensation (IS) was $51.77 million in FY2024 (+4.7%) and $49.43 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation (IS) in data going back to Q1 2024.
- Compared with a year earlier, Share-based Compensation (IS) has declined for six straight quarters, with an average decline of 52.1% over the last six quarters.
- Per Business Quant data, AVIR's Share-based Compensation (IS) in the three quarters before Q2 2026 was $3.73 million (Q1 2026), $4.59 million (Q4 2025) and $4.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Atea Pharmaceuticals | 325.41 Mn | -781.20 Mn | - | 3.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 4.67 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 14.30 Mn |
| Sep 30, 2024 | 12.16 Mn |
| Jun 30, 2024 | 12.72 Mn |
| Mar 31, 2024 | 12.59 Mn |
API Access
Atea Pharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();